Comparing Tri-Lo-Mili vs Tri-Lo-Sprintec
| Tri-Lo-Mili (ethinyl estradiol / norgestimate) | Tri-Lo-Sprintec (ethinyl estradiol / norgestimate) |
|
|---|
| Tri-Lo-Mili (ethinyl estradiol / norgestimate) | Tri-Lo-Sprintec (ethinyl estradiol / norgestimate) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Birth Control. Tri-Lo-Mili may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Endometriosis, Ovarian Cysts, Abnormal Uterine Bleeding, Birth Control, Gonadotropin Inhibition. Tri-Lo-Sprintec may also be used for purposes not listed in this medication guide. |
Related suggestions Birth Control
|
|||||||||||||||
| More about Tri-Lo-Mili (ethinyl estradiol / norgestimate) | More about Tri-Lo-Sprintec (ethinyl estradiol / norgestimate) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Tri-Lo-Mili has an average rating of 6.7 out of 10 from a total of 31 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
Tri-Lo-Sprintec has an average rating of 4.4 out of 10 from a total of 246 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 53% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Tri-Lo-Mili side effects |
View all Tri-Lo-Sprintec side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | Lower cost generic approved | ||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Tri-Lo-Mili prices |
View all Tri-Lo-Sprintec prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other ethinyl estradiol / norgestimate brands include: Estarylla, Femynor, Mili, Mono-Linyah, Nymyo, Previfem, Sprintec, Tri Femynor, Tri-Estarylla, Tri-Linyah, Tri-Lo-Estarylla, Tri-Lo-Linyah, Tri-Lo-Marzia, Tri-Lo-Sprintec, Tri-Mili, Tri-Nymyo, Tri-Previfem, Tri-Sprintec, Tri-VyLibra, Tri-Vylibra Lo, VyLibra View more | Other ethinyl estradiol / norgestimate brands include: Estarylla, Femynor, Mili, Mono-Linyah, Nymyo, Previfem, Sprintec, Tri Femynor, Tri-Estarylla, Tri-Linyah, Tri-Lo-Estarylla, Tri-Lo-Linyah, Tri-Lo-Marzia, Tri-Lo-Mili, Tri-Mili, Tri-Nymyo, Tri-Previfem, Tri-Sprintec, Tri-VyLibra, Tri-Vylibra Lo, VyLibra View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 472 drugs are known to interact with Tri-Lo-Mili:
|
A total of 472 drugs are known to interact with Tri-Lo-Sprintec:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.